Tag: strategies

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson's Disease

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.

Defiance ETFs to Launch SPCU, The 2X SpaceX ETF, as the SpaceX (SPCX) IPO Nears

CHICAGO, June 10, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, along with Morningstar, a leading provider of independent investment insights, today...

Jiangsu, China, June 10, 2026 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (Nasdaq: MTEN) (the “Company”) today announced the closing of its previously announced registered direct offering of 1,131,004 Class A ordinary shares, par value $0.00005 per share (“Class A Ordinary Shares”), at a purchase price of $2.00 per share, and pre-funded warrants to purchase Class A Ordinary Shares at an original exercise price of $2.00, with $1.99995 of the original exercise price pre-funded at the closing, and a remaining exercise price of $0.00005 per Class A Ordinary Share.

AMT's demonstration in FANUC booth #1001 combines collaborative robotics and AI-enabled vision technology for mixed-load palletizing and depalletizing applications in warehouse and logistics environments.ORION,...

Platform supports AI-assisted market monitoring, strategy workflow setup and account activity review

Platform supports AI-assisted market monitoring, strategy workflow setup and account activity review

Rising adoption of AI, IoT, 5G, cloud computing, and real-time applications continues to drive investments in distributed computing infrastructure worldwide.SAN FRANCISCO, June 10, 2026...

Rising adoption of AI, IoT, 5G, cloud computing, and real-time applications continues to drive investments in distributed computing infrastructure worldwide.SAN FRANCISCO, June 10, 2026...

Detailed Program Agenda Released for 2026 Scientific SessionsBOULDER, Colo., June 10, 2026 /PRNewswire/ -- The American Society for Preventive Cardiology (ASPC) announces its 2026...

MoneySimpler, a leading financial technology developer specialising in automated strategy workflows, today announced the official launch and global expansion of its 2026 AI-powered trading automation ecosystem. Built to support retail investors seeking to capture international market opportunities more systematically, the newly deployed framework integrates cryptocurrency, forex, and equity tracking into a unified smart dashboard to maximize data management efficiency for users worldwide.

MoneySimpler, a leading financial technology developer specialising in automated strategy workflows, today announced the official launch and global expansion of its 2026 AI-powered trading automation ecosystem. Built to support retail investors seeking to capture international market opportunities more systematically, the newly deployed framework integrates cryptocurrency, forex, and equity tracking into a unified smart dashboard to maximize data management efficiency for users worldwide.

Global Data Center UPS Market to grow from USD 5.5 billion in 2023 to USD 9.2 billion by 2030 as AI workloads, hyperscale cloud...